These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24530567)

  • 1. Corticosteroid effects on COPD alveolar macrophages: dependency on cell culture methodology.
    Higham A; Lea S; Ray D; Singh D
    J Immunol Methods; 2014 Mar; 405(100):144-53. PubMed ID: 24530567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effects of p38 mitogen-activated protein kinase inhibition with a corticosteroid in alveolar macrophages from patients with chronic obstructive pulmonary disease.
    Armstrong J; Harbron C; Lea S; Booth G; Cadden P; Wreggett KA; Singh D
    J Pharmacol Exp Ther; 2011 Sep; 338(3):732-40. PubMed ID: 21610141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroid insensitive alveolar macrophages from asthma patients; synergistic interaction with a p38 mitogen-activated protein kinase (MAPK) inhibitor.
    Lea S; Harbron C; Khan N; Booth G; Armstrong J; Singh D
    Br J Clin Pharmacol; 2015 May; 79(5):756-66. PubMed ID: 25358442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid sensitivity of lipopolysaccharide-stimulated chronic obstructive pulmonary disease alveolar macrophages.
    Armstrong J; Sargent C; Singh D
    Clin Exp Immunol; 2009 Oct; 158(1):74-83. PubMed ID: 19737233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrapulmonary administration of a p38 mitogen activated protein kinase inhibitor partially prevents pulmonary inflammation.
    Hoogendijk AJ; Pinhanços SS; van der Poll T; Wieland CW
    Immunobiology; 2013 Apr; 218(4):435-42. PubMed ID: 22727776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P38 MAPK and glucocorticoid receptor crosstalk in bronchial epithelial cells.
    Lea S; Li J; Plumb J; Gaffey K; Mason S; Gaskell R; Harbron C; Singh D
    J Mol Med (Berl); 2020 Mar; 98(3):361-374. PubMed ID: 31974640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of corticosteroid insensitivity by p38 MAPK inhibition in peripheral blood mononuclear cells from COPD.
    Khorasani N; Baker J; Johnson M; Chung KF; Bhavsar PK
    Int J Chron Obstruct Pulmon Dis; 2015; 10():283-91. PubMed ID: 25678784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cigarette smoke on Toll-like receptor (TLR) activation of chronic obstructive pulmonary disease (COPD) macrophages.
    Metcalfe HJ; Lea S; Hughes D; Khalaf R; Abbott-Banner K; Singh D
    Clin Exp Immunol; 2014 Jun; 176(3):461-72. PubMed ID: 24528166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of p38 MAPK inhibition on corticosteroid suppression of cytokine release in severe asthma.
    Bhavsar P; Khorasani N; Hew M; Johnson M; Chung KF
    Eur Respir J; 2010 Apr; 35(4):750-6. PubMed ID: 19840967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of corticosteroid insensitivity in COPD alveolar macrophages exposed to NTHi.
    Khalaf RM; Lea SR; Metcalfe HJ; Singh D
    Respir Res; 2017 Apr; 18(1):61. PubMed ID: 28420398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of p38 mitogen-activated protein kinase inhibitors on cytokine release from human macrophages.
    Smith SJ; Fenwick PS; Nicholson AG; Kirschenbaum F; Finney-Hayward TK; Higgins LS; Giembycz MA; Barnes PJ; Donnelly LE
    Br J Pharmacol; 2006 Oct; 149(4):393-404. PubMed ID: 16953188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of lipopolysaccharide-stimulated chronic obstructive pulmonary disease macrophage inflammatory gene expression by dexamethasone and the p38 mitogen-activated protein kinase inhibitor N-cyano-N'-(2-{[8-(2,6-difluorophenyl)-4-(4-fluoro-2-methylphenyl)-7-oxo-7,8-dihydropyrido[2,3-d] pyrimidin-2-yl]amino}ethyl)guanidine (SB706504).
    Kent LM; Smyth LJ; Plumb J; Clayton CL; Fox SM; Ray DW; Farrow SN; Singh D
    J Pharmacol Exp Ther; 2009 Feb; 328(2):458-68. PubMed ID: 19004925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of budesonide on toll-like receptor expression in alveolar macrophages from smokers with and without COPD.
    Ji J; von Schéele I; Billing B; Dahlén B; Lantz AS; Larsson K; Palmberg L
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1035-43. PubMed ID: 27274225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the anti-inflammatory effects of Cilomilast, Budesonide and a p38 Mitogen activated protein kinase inhibitor in COPD lung tissue macrophages.
    Ratcliffe MJ; Dougall IG
    BMC Pharmacol Toxicol; 2012 Nov; 13():15. PubMed ID: 23148608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of repeated Toll-like receptors 2 and 4 stimulation in COPD alveolar macrophages.
    Lea SR; Reynolds SL; Kaur M; Simpson KD; Hall SR; Hessel EM; Singh D
    Int J Chron Obstruct Pulmon Dis; 2018; 13():771-780. PubMed ID: 29535517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages in chronic obstructive pulmonary disease.
    Knobloch J; Hag H; Jungck D; Urban K; Koch A
    Basic Clin Pharmacol Toxicol; 2011 Aug; 109(2):138-43. PubMed ID: 21447053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro modeling of COPD inflammation and limitation of p38 inhibitor - SB203580.
    Meng A; Zhang X; Wu S; Wu M; Li J; Yan X; Kopec-Harding K; Wu J
    Int J Chron Obstruct Pulmon Dis; 2016; 11():909-17. PubMed ID: 27199554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease.
    Russell RE; Culpitt SV; DeMatos C; Donnelly L; Smith M; Wiggins J; Barnes PJ
    Am J Respir Cell Mol Biol; 2002 May; 26(5):602-9. PubMed ID: 11970913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol impairs the release of steroid-resistant inflammatory cytokines from human airway smooth muscle cells in chronic obstructive pulmonary disease.
    Knobloch J; Sibbing B; Jungck D; Lin Y; Urban K; Stoelben E; Strauch J; Koch A
    J Pharmacol Exp Ther; 2010 Dec; 335(3):788-98. PubMed ID: 20801891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-γ synergistically enhances LPS signalling in alveolar macrophages from COPD patients and controls by corticosteroid-resistant STAT1 activation.
    Southworth T; Metryka A; Lea S; Farrow S; Plumb J; Singh D
    Br J Pharmacol; 2012 Aug; 166(7):2070-83. PubMed ID: 22352763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.